Professor David Haslam is a full time GP with a special interest in obesity and cardiometabolic disease, Physician in Obesity Management, Luton & Dunstable Hospital, and Chair of the National Obesity Forum (NOF). The NOF is a charity whose aim is to increase awareness of obesity, diabetes and weight related illness, and improve their management. It provides educational material for clinicians, and also sits upon the Department of Health Obesity Strategy Review Group. He is Visiting Professor, Robert Gordon University, Aberdeen: Visiting Professor Chester University, and is the Obesity Specialist at 76 Harley St. He is a Board Member of ESCO (Experts on Severe and Complex Obesity) and of the charity Foundations, a Director of PCOS UK, a member of the Counterweight Board, and a Visiting Lecturer at Beds & Herts Postgraduate Medical School. He has written a dozen books, and has over 200 articles published in journals and papers and speaks internationally on obesity and related diseases. His books include ‘Fat Gluttony and Sloth, Obesity in Art, Literature and Medicine’, and ‘The Obesity Epidemic, and its Management’, both 2010, and ‘Controversies in Obesity’ and ‘Fast Facts; obesity’ both 2014.
- 01920 830784
Obesity: current and emerging drug treatmentsSubscription
The prevalence of obesity has doubled worldwide since 1980, but a range of new treatments are being introduced to help patients lose weight.
Up to a million more people could be offered weight loss surgery on the NHS after NICE lowered the threshold for which patients are eligible for bariatric surgery. David Haslam, GP and chairman of the National Obesity Forum UK, and David Katz, director, Yale University Prevention Research Center, discuss the merits of the decision, and the use of bariatric